Detalhe da pesquisa
1.
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
JAMA Oncol
; 5(5): 623-632, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703190